It should be noted that the relative activity of antibodies from the cerebrospinal fluid of multiple sclerosis patients in the hydrolysis of DNA, MBP, and polysaccharides, depending on the substrate, is 30–60 times higher than that from the blood of the same patients [22,23,24]. The gene discussed is MBP; the disease is multiple sclerosis.